Featured Research

from universities, journals, and other organizations

Serotonin May Hold Key To Hyperactivity Disorder

Date:
January 20, 1999
Source:
Howard Hughes Medical Institute
Summary:
Much concern has been raised over prescribing Ritalin® or other stimulants to control hyperactivity disorders in children. Relatively little is known about the long-term effects of these stimulants or how they alter brain chemistry. Now researchers at the Howard Hughes Medical Institute at Duke University have discovered that Ritalin® and other stimulants exert their paradoxical calming effects by boosting serotonin levels in the brain.

January 15, 1999 — Much concern has been raised over prescribing Ritalin® or other stimulants to control hyperactivity disorders in children. Relatively little is known about the long-term effects of these stimulants or how they alter brain chemistry.

Related Articles


Now researchers at the Howard Hughes Medical Institute at Duke University have discovered that Ritalin® and other stimulants exert their paradoxical calming effects by boosting serotonin levels in the brain. Elevating serotonin appears to restore the delicate balance between the brain chemicals dopamine and serotonin and calms hyperactivity, says HHMI investigator Marc Caron at Duke University Medical Center. Caron is an author of the study published in the January 15, 1999, issue of the journal Science.

Attention deficit hyperactivity disorder (ADHD) affects three to six percent of school-aged children. Symptoms include restlessness, impulsiveness, and difficulty concentrating. Stimulants commonly used to treat ADHD are so effective that "researchers haven't really taken the time to investigate how they work," says Caron.

Previous dogma, says Caron, held that the calming action of Ritalin® works through the neurotransmitter dopamine. Specifically, researchers believed that Ritalin® and other stimulants interact with the dopamine transporter protein (DAT), a housekeeper of sorts for nerve pathways. After a nerve impulse moves from one neuron to another, DAT removes residual dopamine from the synaptic cleft-the space between two neurons-and repackages it for future use.

Caron's team suspected that dopamine wasn't the only key to understanding ADHD, so they turned to mice in which they had "knocked out" the gene that codes for DAT. Since there is no DAT to "mop up" dopamine from the synaptic cleft, the brains of the mice are flooded with dopamine. The excess dopamine causes restlessness and hyperactivity, behaviors that are strikingly similar to those exhibited by children with ADHD.

When placed in a maze that normal mice negotiate in less than three minutes, the knockout mice became distracted-performing extraneous activities such as sniffing and rearing-and they failed to finish in less than five minutes. The knockout mice also seemed unable to suppress inappropriate impulses-another hallmark of ADHD.

Surprisingly, the knockout mice were still calmed by Ritalin®, Dexedrine® and other stimulants even though they lacked the protein target on which Ritalin® and Dexedrine® were thought to act. "That caused us to look for other systems that these stimulants might affect," says Caron.

To test whether the stimulants interact with dopamine through another mechanism, the researchers administered Ritalin® to the normal and knockout mice and monitored their brain levels of dopamine. Ritalin® boosted dopamine levels in the normal mice, but it did not alter dopamine levels in knockout mice. That result implied that "Ritalin® could not be acting on dopamine," says Caron.

Next, the researchers gave the knockout mice a drug that inactivates the norepinephrine transport protein. With transport disabled, norepinephrine levels increased as expected, but the boost in norepinephrine did not ameliorate the symptoms of ADHD as it should. This suggested to Caron's team that Ritalin® exerted its effects through another neurotransmitter.

They then studied whether the stimulants altered levels of the neurotransmitter serotonin. The scientists administered Prozac®-a well-known inhibitor of serotonin reuptake-to the knockout mice. After ingesting Prozac®, the knockout mice showed dramatic declines in hyperactivity.

"This suggests that rather than acting directly on dopamine, the stimulants create a calming effect by increase serotonin levels," Caron says.

"Our experiments imply that proper balance between dopamine and serotonin are key," says Raul Gainetdinov, a member of Caron's research team. "Hyperactivity may develop when the relationship between dopamine and serotonin is thrown off balance."

The brain has 15 types of receptors that bind to serotonin, and Gainetdinov is now trying to determine which specific serotonin receptors mediate the effects of Ritalin®.

The hope, says Caron, "is that we can replace Ritalin® with a very specific compound that targets a single subset of receptors." While Prozac® calmed hyperactivity in the knockout mice, Gainetdinov says that "Prozac® isn't the best, because it isn't very selective." Caron and Gainetdinov are optimistic that a new generation of compounds that interact more specifically with the serotonin system will prove to be safer and more effective for treatments for ADHD.


Story Source:

The above story is based on materials provided by Howard Hughes Medical Institute. Note: Materials may be edited for content and length.


Cite This Page:

Howard Hughes Medical Institute. "Serotonin May Hold Key To Hyperactivity Disorder." ScienceDaily. ScienceDaily, 20 January 1999. <www.sciencedaily.com/releases/1999/01/990120074604.htm>.
Howard Hughes Medical Institute. (1999, January 20). Serotonin May Hold Key To Hyperactivity Disorder. ScienceDaily. Retrieved November 25, 2014 from www.sciencedaily.com/releases/1999/01/990120074604.htm
Howard Hughes Medical Institute. "Serotonin May Hold Key To Hyperactivity Disorder." ScienceDaily. www.sciencedaily.com/releases/1999/01/990120074604.htm (accessed November 25, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Tuesday, November 25, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

From Popcorn To Vending Snacks: FDA Ups Calorie Count Rules

From Popcorn To Vending Snacks: FDA Ups Calorie Count Rules

Newsy (Nov. 25, 2014) — The US FDA is announcing new calorie rules on Tuesday that will require everywhere from theaters to vending machines to include calorie counts. Video provided by Newsy
Powered by NewsLook.com
Daily Serving Of Yogurt Could Reduce Risk Of Type 2 Diabetes

Daily Serving Of Yogurt Could Reduce Risk Of Type 2 Diabetes

Newsy (Nov. 25, 2014) — Need another reason to eat yogurt every day? Researchers now say it could reduce a person's risk of developing type 2 diabetes. Video provided by Newsy
Powered by NewsLook.com
Madagascar Working to Contain Plague Outbreak

Madagascar Working to Contain Plague Outbreak

AFP (Nov. 24, 2014) — Madagascar said Monday it is trying to contain an outbreak of plague -- similar to the Black Death that swept Medieval Europe -- that has killed 40 people and is spreading to the capital Antananarivo. Duration: 00:42 Video provided by AFP
Powered by NewsLook.com
Are Female Bosses More Likely To Be Depressed?

Are Female Bosses More Likely To Be Depressed?

Newsy (Nov. 24, 2014) — A new study links greater authority with increased depressive symptoms among women in the workplace. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins